Korro Bio Inc.

21.70
-1.26 (-5.49%)
At close: Mar 04, 2025, 3:59 PM
21.79
0.41%
After-hours: Mar 04, 2025, 04:00 PM EST

Korro Bio Cash Flow Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Net Income -81.17M -58.03M -21.96M -26.51M -18.75M -19.17M -20.24M
Depreciation & Amortization 3.63M 2.51M 1.59M 1.58M 813K 654K 531K
Stock-Based Compensation 2.38M 1.14M 807K n/a n/a n/a n/a
Other Working Capital 1.18M -2.39M 848K -34.53M 49.29M 819K 276K
Other Non-Cash Items 3.61M 1.51M -13.47M 8.86M 5.77M 1.98M 5.88M
Deferred Income Tax -15K -145K 28K n/a n/a n/a n/a
Change in Working Capital 4.28M -633K 904K -30.24M 48.65M 819K 276K
Operating Cash Flow -67.28M -53.65M -32.09M -45.19M 34.22M -17.02M -14.61M
Capital Expenditures -7.84M -5.21M -4.45M -6.67M -1.06M -436K -1.86M
Acquisitions n/a n/a -29.23M n/a n/a 3.77M n/a
Purchase of Investments n/a -37.21M -35.07M -26.34M -282.62M n/a n/a
Sales Maturities Of Investments 19M 53.48M 29.23M 43.42M 265.42M n/a n/a
Other Investing Acitivies n/a 16.27K 13K n/a n/a n/a n/a
Investing Cash Flow 11.16M 11.06M -39.5M 10.4M -18.26M 3.34M -1.86M
Debt Repayment n/a n/a n/a 15M n/a 5M n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 69.81M 18K 115.94M n/a n/a n/a n/a
Financial Cash Flow 187.76M 18K 115.94M 56.69M 142.01M 37.94M 27.98M
Net Cash Flow 131.64M -42.57M 44.35M 20.18M 157.97M 24.25M 11.5M
Free Cash Flow -75.12M -58.86M -36.54M -51.86M 33.15M -17.46M -16.48M